Seeing Is Believing
Currently out of the existing stock ratings of Hartaj Singh, 112 are a BUY (93.33%), 1 are a SELL (0.83%), 7 are a HOLD (5.83%).
Analyst Hartaj Singh works at OPPENHEIMER with a stock forecast success ratio of 37.27% fulfilled within 205.8 days on average.
Hartaj Singh’s has documented 247 price targets and ratings displayed on 25 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on GILD, Gilead Sciences at 12-Feb-2024.
Analyst best performing recommendations are on ONCT (ONCTERNAL THERAPEUTICS).
The best stock recommendation documented was for MRNA (MODERNA) at 4/15/2020. The price target of $43 was fulfilled within 2 days with a profit of $5.75 (15.44%) receiving and performance score of 77.18.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
205
$22.5 (12.33%)
2 years 11 months 14 days ago
3/5 (60%)
$35.09 (20.65%)
938
Hold
173
$-9.5 (-5.21%)
156
2 years 11 months 16 days ago
14/24 (58.33%)
$2.73 (1.60%)
682
Hold
190
$7.5 (4.11%)
194
3 years 2 months 15 days ago
9/11 (81.82%)
$34.41 (22.12%)
350
Hold
166
$-16.5 (-9.04%)
175
3 years 2 months 15 days ago
23/23 (100%)
$10.41 (6.69%)
828
Buy
155
3 years 3 months 12 days ago
7/7 (100%)
$36.79 (31.12%)
395
Which stock is Hartaj Singh is most bullish on?
Which stock is Hartaj Singh is most reserved on?
What Year was the first public recommendation made by Hartaj Singh?